Otú Antacid Si Chebe Gị Site na Reflux Acid
Gaviscon bụ ihe na-agafe agafe (OTC) na ihe na-emepụta ihe mgbochi nke na-egbochi njiko nke esophagus na afo. Mụta otú o si arụ ọrụ iji gbochie ma ọ bụ belata mgbaàmà nke nrekasi obi na ihe ị ga-eji ọgwụ a.
Isi
Na mgbakwunye na ihe ndị acid neutralizing dị n'ọtụtụ antacids (aluminum hydroxide na magnesium carbonate), Gaviscon nwere alginic acid na sodium bicarbonate.
Ngwakọta nke alginic acid na bicarbonate na-emepụta mgbochi ụfụfụ nke na-efegharị na afo acid. Ihe mgbochi gel a na-ekpuchi akpa n'akpa a na-etinye na ngwongwo nke esophagus na afo na o nwere ike inye aka belata onu ogugu reflux. O nwekwara ike inye ihe na-adịgide adịgide megide ọrịa nrekasi obi na ndị nwere ọrịa reflux gastroesophage (GERD) .
Uru
Ọtụtụ nchọpụta achọpụtawo na Gaviscon nwere ike ibelata mgbaàmà nke nrịkasi obi maka ndị nwere reflux acid. Maka ọrịa dị nro, ọ nwere ike iji ya naanị ya. Maka ndị nwere reflux siri ike, o yiri ka Gavison nwekwara ike inye aka maka ndị na-enweghi mmeghachi omume na proton pump inhibitors . Na mgbakwunye na mbelata mgbaàmà na ọnụ ọgụgụ ngosipụta reflux, Gaviscon na-egosi ka ọ na-ebelata postprandial (mgbe ọ na-eri) ogo acid n'ime esophagus dị ka atụpụtara site na nyocha pH.
Efrata na nkọwa ngwaahịa
Ike na-aga n'ihu (na mbadamba ọ bụla)
- Aluminium Hydroxide 80 miligrams
- Magnesium Trisilicate 20 milligrams
Mpempe akwụkwọ ike ọzọ (na mbadamba ọ bụla)
- Aluminom Hydroxide 160 milligrams
- Magnesium Carbonate 105 milligrams
Ike Liquid mgbe nile (na tablespoon ọ bụla)
- Mkpụrụ ọka Hydroxide 95 nke aluminium
- Magnesium Carbonate 358 milligrams
Extra Strength Liquid (na teaspoon ọ bụla)
- Alloy hydroxide 254 milligrams
- Magnesium carbonate 237.5 milligrams
Njikere
Gaviscon na-abịa dị ka mbadamba ụrọ na mmiri mmiri iji were n'ọnụ. Maka ọgwụ ị ga-arụ ọrụ nke ọma, ị ga-ehichapụ mbadamba nkume ndị ahụ ma ghara ikpo ha dum. Ṅụọ otu iko mmiri zuru ezu mgbe ị nara mbadamba nkume. Kpoo mmiri mmiri na-eme ka ọnụ mmiri gwọọ tupu gị ejikọta ọgwụ ahụ. A pụrụ itinye mmiri mmiri na mmiri ma ọ bụ mmiri ara ehi.
Soro ntụziaka dị na ngwugwu ngwugwu ma ọ bụ na labelị ọgwụ gị nke ọma, ma jụọ dọkịta gị ma ọ bụ onye na-ahụ maka ọgwụ ike ịkọwa akụkụ ọ bụla ị na-aghọtaghị. Were aluminum hydroxide na magnesium antacids kpọmkwem dị ka a gwara. Ejila ihe ma ọ bụ na-erughị ya ma ọ bụ buru ya karịa oge dọkịta gị nyere iwu. Ejila ihe karịrị otu izu ruo izu abụọ ọ gwụla ma dọkịta gị nyere iwu.
Nlekọta Ndị Mkpa
Were nlezianya ndị a iji nweta nsonaazụ kacha mma ma wedata mmetụta ndị ọzọ:
- Gwa onye dọkịta gị na onye na-ahụ maka ọgwụ ike ma ọ bụrụ na ị na-enwe nchekasị na carbonate carbonate na ihe ọ bụla ọzọ ịrịa. Mmeghachi omume ọjọọ nwere ike ime n'ihi na arụghị arụ ọrụ kama ịrụ ọrụ na-arụ ọrụ na ọgwụ.
- Gwa dọkịta gị na onye na-ahụ maka ọgwụ na ọgwụ ndị ị na-ewere. Ọ dị mkpa ịdepụta ọ bụghị naanị ọgwụ ndị e nyere gị ugbu a, ma ọ bụ ọgwụgwọ, vitamin, ma ọ bụ ihe mgbakwunye / nri ọgwụ ndị ị na-ewere. Dabere na ọgwụ ndị ọzọ gị, dọkịta gị ga-enwe ike ịgwa gị ma ị nwere ike iji ọgwụ ndị a na-enye nsogbu, ma ọ bụrụ na ọ bụ, oge kachasị mma n'ụbọchị iji ọgwụ ahụ. Maka ọgwụ dị iche iche, a na-atụ aro ka ichere na ọ dịkarịa ala awa abụọ mgbe ị gwakịrị ọgwụ iji jide n'aka na ịṅụ ọgwụ ọzọ.
- Gwa dọkịta gị ma ọ bụrụ na ị nwere ma ọ bụ nwee ọrịa akụrụ ma ọ bụ nsogbu afo.
- Gwa dọkịta gị ma ọ bụrụ na ị dị ime, na-ezube ịtụrụ ime, ma ọ bụ na-enye gị ara. Ọ bụrụ na ị dị ime mgbe ị na-eji ọgwụ ndị nwere calcium carbonate, dịka Gaviscon, kpọọ dọkịta gị.
Mmetụta dị n'akụkụ
Mmetụta dị na Gaviscon anaghị adịkarị. N'ezie, nchọpụta afọ 2016 nke na-ele mmetụta nke Gaviscon maka nkuchi obi anaghị achọpụta mmetụta dị iche n'etiti ndị na-eji Gaviscon na ndị na-ewere placebo. Ma, enwere mmetụta ndị nwere ike ime. Gwa dọkịta gị ma ọ bụrụ na otu n'ime mgbaàmà ndị a dị njọ maọbụ na ị gaghị apụ:
- Upset afo
- Vomiting
- Na-egbu mgbu
- Egwuregwu
- Nkwado
- Ọnụ oyi
- Ịmalite urination
- Enweghi agụụ
- Ezigbo uto
Isi mmalite:
> Reimer C, Lødrup AB, Smith G, Wilkinson J, Bytzer P. Nchọpụta Clinical Randomized: Alginate (Gaviscon Advance) vs. Ebe nchekwa dị ka ọgwụ ntinye ọgwụ na Reflux ndị ọrịa na ezighi ezi azaghachi otu ugboro Daily Proton Pump Inhibitor. Ihe oriri na-edozi ọgwụ & ọgwụgwọ 43, mba. 8 (2016): 899-909. Echiche: 10.1111 / apt.13567.
> Thomas E., Wade A., Crawford G., Jenner B., Levinson N., Wilkinson J. Nyocha Clinical Trial: Enyemaka nke Mkpụrụ Ahụhụ Gastrointestinal Dị Elu site na Acid Pocket-Targeting Alginate-Antacid (Gaviscon Double Action) - A ugboro abụọ -Blind, Na-achịkwa Control, Nyocha Ọmụmụ Pilot na Gastro-onesophageal Reflux Ọrịa. Ọgwụ Nkà Ọgwụ na Ọgwụgwọ . 2014. 39 (6): 595-602.
> Yuan YZ, Fang JY, Zou DW, Levinson N, Jenner B, Wilkinson J. Alginate-Antacid (Gaviscon Dual Action) Tablets Chewable Belata Esophageal Acid Exposure na Chinese Patients with Gastroesophageal Reflux Disease and Heartburn Symptoms s. Nyocha nke Ọrịa Na-egbu Ọkụ . 2016; 17 (11): 725-734. Echiche: 10.1111 / 1751-2980.12406.